Proffitt & Goodson Inc Repligen Corp Transaction History
Proffitt & Goodson Inc
- $694 Million
- Q3 2025
A detailed history of Proffitt & Goodson Inc transactions in Repligen Corp stock. As of the latest transaction made, Proffitt & Goodson Inc holds 10 shares of RGEN stock, worth $1,611. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10Holding current value
$1,611% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding RGEN
# of Institutions
511Shares Held
59MCall Options Held
89.3KPut Options Held
679K-
Black Rock Inc. New York, NY7.57MShares$1.22 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.6MShares$1.06 Billion0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.08MShares$818 Million0.01% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct1.91MShares$308 Million0.53% of portfolio
-
State Street Corp Boston, MA1.62MShares$261 Million0.01% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $8.94B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....